de evaluación de tratamientos, intervenciones y análisis nuevos como medio para prevenir, detectar, tratar o controlar esta enfermedad. La neuromielitis óptica (NMO) o enfermedad de Devic es un trastorno autoinmune, inflamatorio y desmielinizante, que afecta principalmente al nervio óptico y la. INTRODUCTION: Neuromyelitis optica (NMO), or Devic’s disease, is an La neuromielitis optica (NMO) o enfermedad de Devic es un.
|Published (Last):||6 February 2007|
|PDF File Size:||12.7 Mb|
|ePub File Size:||9.93 Mb|
|Price:||Free* [*Free Regsitration Required]|
Rethinking Neuromyelitis Optica Devic disease. Anatomical study of two cases. Neurologist, 11pp.
Historia de la enfermedad de Devic | Revista Colombiana de Reumatología
Multiple Sclerosis in the Japanese population. The patient was diagnosed as suffering from encephalopathy within the context of NMO and she was treated with intravenous immunoglobulins and corticoids, which resulted in a clinical and radiological improvement. Criterios principales de soporte: Magnetic resonance imaging in isolated non-compressive spinal cord syndromes.
El abdomen estaba blando, devif ruidos intestinales normales, sin masas ni visceromegalias. J Neurol Sci, 82pp. Revised diagnostic criteria for neuromyelitis optica. And Arch Neurol, 36pp.
There was a problem providing the content you requested
Se continuar a navegar, consideramos que aceita o seu uso. Neurology, 26pp. Patterns of disease activity in multiple sclerosis: Lancet, 1pp. A randomized trial of plasma exchange in acute central nervous devix inflammatory demyelinating disease.
Lupus, 16pp. Since the discovery of AQ-4 antibodies, there has been an increase enfermedax the number of clinical and radiological manifestations of NMO beyond involvement of the optic nerve and the spinal cord, including manifestations in the brain. Neurology, 73pp. J Neurosurg Psychiatry, 53pp.
However the discovery of NMO IgG antibodies directed against aquaporin-4 water channels was a critical step in such differentiation. Med, 23pp. J Med Case Reports, 2pp. Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus.
Intermittent plasmapheresis prevents recurrence in neuromyelitis optica. Intracerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Spinal cord lesions in patients enfwrmedad neuromyelitis optica: Borderlines types of Multiple Sclerosis. On the ophthalmoscopic enfermerad of spinal disease. Successful high dose glucocorticoid treatment for subacute neuromyelitis optica with systemic lupus erythematosus.
Ophthalmic Review, 34pp.
The molecular basis of water transport in the brain. F Neurosurg Psychiatry, 58pp. A clinical comparative study of multiple sclerosis and neuro- Behcet’s syndrome, Journal of Neurology.
Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis enfermedae and multiple sclerosis. Mult Scler ; Estos criterios fueron precedidos por los criterios de Mandler en 3 y de O’Riordan en European J Neurol, 17pp.
Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Is Devic’s neuromyelitis optica a separate disease? An open label study of the effects of rituximab in neuromyelitis optica.
Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders. Neurol ; 60 5 Suppl 1: Oligoclonal bands in Devic’s neuromyelitis optica and multiple sclerosis: Neurosurgery and Psychiatry, 43pp. J Fr Ophtalmol, 31pp. Anti-aquaporin-4 AQ-4 antibodies are a specific biomarker of the entity and, since their discovery, both the number of symptoms and the radiological data about the disease have progressively increased, and the concept of clinical spectrum of NMO has been defined.
The Adv Neurol Disord, 3pp. Risk factors for multiple sclerosis: Rheumatology Oxford44pp. Curr Opin Neurol ; In this paper we do a complete review of Devic’s disease, from its first descriptions by Eugene Devic, to the current concept, which is considered a neuromyelitis optica NMO.